Tue, August 3, 2021
Mon, August 2, 2021
Sun, August 1, 2021
Fri, July 30, 2021
Thu, July 29, 2021
Wed, July 28, 2021

Matthew Harrison Maintained (VRTX) at Hold with Decreased Target to $202 on, Jul 30th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-202-on-jul-30th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold with Decreased Target from $205 to $202 on, Jul 30th, 2021.

Matthew has made no other calls on VRTX in the last 4 months.



There are 10 other peers that have a rating on VRTX. Out of the 10 peers that are also analyzing VRTX, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021


These are the ratings of the 9 analyists that currently disagree with Matthew


  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $331 on, Monday, June 14th, 2021
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $307 on, Friday, June 11th, 2021
  • Mohit Bansal of "Citigroup" Maintained at Strong Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $244 on, Friday, June 11th, 2021
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $281 on, Friday, June 11th, 2021
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $240 on, Friday, June 11th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $260 on, Monday, May 3rd, 2021

Publication Contributing Sources